Citation(s)
- Case MT, Smith JK, Nelson RA
Chronic oral toxicity studies of nefopam hydrochloride in rats and dogs. Toxicol Appl Pharmacol. 1976 May;36(2):301-6. doi: 10.1016/0041-008x(76)90009-0. No abstract available.
- Case MT, Smith JK, Nelson RA
Reproductive, acute and subacute toxicity studies with nefopam in laboratory animals. Toxicol Appl Pharmacol. 1975 Jul;33(1):46-51. doi: 10.1016/0041-008x(75)90242-2. No abstract available.
- Dunkin CSJ, Pleat JM, Gillespie PH, Tyler MPH, Roberts AHN, McGrouther DA
Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg. 2007 May;119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
- Honardoust D, Varkey M, Marcoux Y, Shankowsky HA, Tredget EE
Reduced decorin, fibromodulin, and transforming growth factor-beta3 in deep dermis leads to hypertrophic scarring. J Burn Care Res. 2012 Mar-Apr;33(2):218-27. doi: 10.1097/BCR.0b013e3182335980.
- Mather GG, Labroo R, Le Guern ME, Lepage F, Gillardin JM, Levy RH
Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration. Chirality. 2000 Mar;12(3):153-9. doi: 10.1002/(SICI)1520-636X(2000)12:33.0.CO;2-V.
- Poon R, Hong H, Wei X, Pan J, Alman BA
A high throughput screen identifies Nefopam as targeting cell proliferation in beta-catenin driven neoplastic and reactive fibroproliferative disorders. PLoS One. 2012;7(5):e37940. doi: 10.1371/journal.pone.0037940. Epub 2012 May 30.
A Randomized, Placebo Controlled, Double-Blind, Single Dose Study To Evaluate The Safety And Tolerability Of Cream In Burn Patients With Induced Dermal Incisions
Details for clinical trial NCT04685577
